St Germain D J CO Inc Halozyme Therapeutics, Inc. Transaction History
St Germain D J CO Inc
- $2.22 Billion
- Q2 2025
A detailed history of St Germain D J CO Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, St Germain D J CO Inc holds 2,730 shares of HALO stock, worth $164,018. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,730Holding current value
$164,018% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
583Shares Held
122MCall Options Held
308KPut Options Held
131K-
Black Rock Inc. New York, NY17.6MShares$1.06 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$771 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$364 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$234 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$221 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.37B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...